scispace - formally typeset
M

Michael L. Bennish

Researcher at University of Oxford

Publications -  70
Citations -  5176

Michael L. Bennish is an academic researcher from University of Oxford. The author has contributed to research in topics: Shigellosis & Population. The author has an hindex of 36, co-authored 70 publications receiving 5023 citations. Previous affiliations of Michael L. Bennish include University of Natal & Tufts University.

Papers
More filters
Journal ArticleDOI

Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study

TL;DR: The association between mixed breastfeeding and increased HIV transmission risk, together with evidence that exclusive breastfeeding can be successfully supported in HIV-infected women, warrant revision of the present UNICEF, WHO, and UNAIDS infant feeding guidelines.
Journal ArticleDOI

Analysis of Sequence Diversity at the Highly Polymorphic Cpgp40/15 Locus among Cryptosporidium Isolates from Human Immunodeficiency Virus-Infected Children in South Africa

TL;DR: This study analyzed nucleic acid and amino acid sequence polymorphism at the Cpgp40/15 locus of 20 C. parvum isolates from HIV-infected South African children to identify children infected with isolates having genotype Ic alleles, raising the possibility of sexual recombination within and between prototypal parasite genotypes.
Journal ArticleDOI

Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial.

TL;DR: The efficacy of the macrolide agent azithromycin for treating shigellosis was evaluated and the oral form of the extended-spectrum cephalosporin cefixime, although active in vitro against multidrug-resistant Shigella strains, was ineffective in achieving clinical and bacteriologic cure.
Journal ArticleDOI

Potentially lethal complications of shigellosis.

TL;DR: Management of broad-spectrum empiric antibiotic treatment of all severely ill, malnourished patients with shigellosis as well as frequent feedings to prevent hypoglycemia and realistic approaches to the reduction of mortality must continue to focus on prevention and early antimicrobial therapy.